Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)

SHE:002365 Revenue

Qianjiang Yongan Pharmaceutical had revenue of 385.00M CNY in the quarter ending September 30, 2026, with 83.53% growth. This brings the company's total for the last twelve months to 1.15B, up 44.84% year-over-year. In the year 2025, Qianjiang Yongan Pharmaceutical had annual revenue of 783.17M, down -6.63%. That makes Qianjiang Yongan Pharmaceutical the 18,529th largest company in the world by revenue and 3,386th in China.

• Revenue (ttm): 1.15B
• Revenue Growth: +44.84%
• P/S Ratio: 3.01
• Revenue / Employee: 1.27M
• Employees: 912
• Market Cap: 3.45B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Manufacturing 494.97M 63.2%
• Health Foods 210.21M 26.8%
• Chemical Manufacturing 73.11M 9.3%
• Others 4.88M 0.6%

By Geography

Chart

• Overseas 405.58M 51.8%
• China 377.58M 48.2%

Fiscal year ended Dec 31, 2025 See the full SHE:002365 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	783.17M	-55.65M	-6.63%
Dec 31, 2024	838.81M	-134.08M	-13.78%
Dec 31, 2023	972.89M	-489.56M	-33.48%
Jan 1, 2023	1.46B	-102.96M	-6.58%
Jan 1, 2022	1.57B	392.56M	33.47%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error